Virex Pharma Awarded ~$500K of WA Future Health Research Innovation Fund (FHRIF) Innovation Seed Fund (ISF) Grant
Virex Pharma is honoured to announce it has been awarded $499,241 to develop GlyXine© its
News
Virex Pharma is a finalist in WA Innovator of the Year 2023
Virex Pharma Ltd is pleased to announce it is a finalist in the Western Australia
Virex Pharma and Respien sign Binding Agreement to Merge
Virex Pharma and Respien sign Binding Agreement to Merge Virex Pharma Ltd (Virex) is pleased
Virex Pharma Ltd Announces Completion of In Vitro Studies for Revolutionary Inhaled Antiviral Treatment for RSV
Virex Pharma Ltd Announces Completion of In Vitro Studies for Revolutionary Inhaled Antiviral Treatment for
Virex Pharma Ltd Appoints Dr Greg Pullen as a Non-Executive Director
Virex Pharma Ltd is pleased to announce the appointment of Dr Greg Pullen as a
Virex Pharma’s novel nanoemulsion formulation shows promising antiviral activity against Respiratory Syncytial Viruses and Coronaviruses
Independent accredited contract research organisations were engaged to carry out studies with Virex Pharma’s nanoemulsion